Patrick Karabon
Papers
1
Total Citations
215
H-Index
1
About
Patrick Karabon is a biostatistician and health outcomes researcher whose work bridges the gap between rigorous statistical methodology and impactful clinical practice. His primary research areas include urologic oncology, surgical outcomes, and pragmatic clinical trial design. Karabon is perhaps best known for his pivotal role in a landmark 2017 pragmatic randomized controlled trial examining the Retzius-sparing approach during robot-assisted radical prostatectomy, which demonstrated significant improvements in early urinary continence recovery. This highly cited study (215 citations) has influenced surgical techniques worldwide, helping to reduce post-operative morbidity for prostate cancer patients. Beyond this flagship work, Karabon has contributed extensively to evidence-based medicine through collaborative studies on cancer survivorship, comparative effectiveness research, and advanced statistical modeling. His expertise in designing and analyzing pragmatic trials has made him a sought-after collaborator, with his work collectively cited thousands of times. Karabon’s ability to translate complex data into actionable clinical insights continues to shape modern urologic practice and patient-centered outcomes research.
Research Focus
Key Achievements
Top Papers
- 1